Agios Pharmaceuticals Inc

NASDAQ:AGIO   3:59:57 PM EDT
49.70
-0.49 (-0.98%)
Products

Agios Submits New Drug Application To FDA For Mitapivat For Treatment Of Adults With Pyruvate Kinase Deficiency

Published: 06/21/2021 11:54 GMT
Agios Pharmaceuticals Inc (AGIO) - Agios Submits New Drug Application to FDA for Mitapivat for Treatment of Adults With Pyruvate Kinase Deficiency.